Cardiovascular Disease & Comorbidities in SpA

Host: Anisha Dua, MD, MPH <br> Guest: Elaine Husni, MD, MPH <br> <p>Patients with spondyloarthritis, or SpA for short, can be at an increased cardiovascular risk.^1,2 To learn how we can better understand and manage this risk, Dr. Anisha Dua is joined by Dr. Elaine Husni from the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.</p> <p><em>Dr. Dua and Dr. Husni are Novartis consultants.</em></p> <ol> <li>Zhao SS, Robertson S, Reich T, Harrison NL, Moots RJ, Goodson NJ. Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis. <em>Rheumatol (United Kingdom)</em>. 2020;59:iv47-iv57.</li> <li>Papagoras C, Markatseli TE, Saougou I, et al. Cardiovascular risk profile in patients with spondyloarthritis. <em>Jt Bone Spine</em>. 2014;81(1):57-63.</li> </ol> <p style="text-align: right;">196466 6/22</p>